A study presented at the United European Gastroenterology Week in Berlin found that consuming sugary or artificially sweetened drinks increases the risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD). The research followed 123,788 UK participants over a decade, revealing that sugar-sweetened beverages (SSBs) raised MASLD risk by 50%, while low or no-sugar beverages (LNSSBs) increased it by 60%. The study emphasizes the need to reconsider the perceived safety of these drinks and suggests practical strategies for reducing liver disease risk. Teljes cikk (Euronews.com)